Skip to main content

Advertisement

SpringerLink
Log in

Impact of Geographic and Transportation-Related Barriers on HIV Outcomes in Sub-Saharan Africa: A Systematic Review

  • Substantive Review
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Difficulty obtaining reliable transportation to clinic is frequently cited as a barrier to HIV care in sub-Saharan Africa (SSA). Numerous studies have sought to characterize the impact of geographic and transportation-related barriers on HIV outcomes in SSA, but to date there has been no systematic attempt to summarize these findings. In this systematic review, we summarized this body of literature. We searched for studies conducted in SSA examining the following outcomes in the HIV care continuum: (1) voluntary counseling and testing, (2) pre-antiretroviral therapy (ART) linkage to care, (3) loss to follow-up and mortality, and (4) ART adherence and/or viral suppression. We identified 34 studies containing 52 unique estimates of association between a geographic or transportation-related barrier and an HIV outcome. There was an inverse effect in 23 estimates (44 %), a null association in 26 (50 %), and a paradoxical beneficial impact in 3 (6 %). We conclude that geographic and transportation-related barriers are associated with poor outcomes across the continuum of HIV care.

Resúmen

Las dificultades para obtener un transporte confiable a la clínica son frecuentemente citadas como una barrera para la atención del VIH en el África subsahariana; sin embargo, la magnitud de este efecto es desconocido. En esta reseña sistemática, resumimos la literatura sobre el impacto de las barreras geográficas y de transporte en los resultados relacionados con el VIH en el África subsahariana. Se buscaron estudios realizados en el África subsahariana examinando los siguientes resultados en el continuo de la atención del VIH: 1) asesoramiento y pruebas voluntarias, 2) vinculo a los servicios antes de empezar el tratamiento antirretroviral (ART), 3) pérdida en el seguimiento y la mortalidad, y 4) adherencia al ART y/o la supresión viral. Se identificaron 34 estudios que contienen 52 estimaciones únicas de asociación entre una barrera geográfica o relacionados al transporte y el resultado de VIH. Se produjo un efecto adverso en 23 estimaciones (44 %), una asociación nula en 26 (50 %), y un impacto paradójico beneficioso en 3 (6 %). Se concluyó que las barreras geográficas y relacionadas con el transporte están asociadas con resultados pobres de todo el continuo de la atención del VIH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Cain LE, Logan R, Robins JM, et al. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med. 2011;154(8):509–15.

    Article  PubMed  Google Scholar 

  3. Severe P, Juste MA, Ambroise A, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med. 2010;363(3):257–65.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Maman D, Pujades-Rodriguez M, Nicholas S, et al. Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/ml. AIDS. 2012;26(11):1393–8.

    Article  CAS  PubMed  Google Scholar 

  5. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57.

    Article  PubMed  Google Scholar 

  6. Hammer SM. Antiretroviral treatment as prevention. N Engl J Med. 2011;365(6):561–2.

    Article  CAS  PubMed  Google Scholar 

  7. Geng EH, Hare CB, Kahn JO, et al. The effect of a “universal antiretroviral therapy” recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/mL in a public health setting. Clin Infect Dis. 2012;55(12):1690–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. World Health Organization, UNAIDS, UNICEF. Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access; 2011.

  9. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367(9513):817–24.

    Article  PubMed  Google Scholar 

  10. Brinkhof MW, Spycher BD, Yiannoutsos C, et al. Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. PLoS ONE. 2010;5(11):e14149.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Gupta A, Nadkarni G, Yang WT, et al. Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS ONE. 2011;6(12):e28691.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897–908.

    Article  PubMed  Google Scholar 

  13. Marazzi MC, Liotta G, Germano P, et al. Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Res Hum Retrovir. 2008;24(4):555–60.

    Article  CAS  PubMed  Google Scholar 

  14. Kigozi IM, Dobkin LM, Martin JN, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52(2):280–9.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Katz IT, Essien T, Marinda ET, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS. 2011;25(17):2177–81.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Losina E, Bassett IV, Giddy J, et al. The “ART” of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS ONE. 2010;5(3):e9538.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Bassett IV, Regan S, Chetty S, et al. Who starts antiretroviral therapy in Durban, South Africa?… not everyone who should. AIDS. 2010;24(Suppl 1):S37–44.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Geng EH, Nash D, Kambugu A, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7(4):234–44.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007;21(8):965–71.

    Article  CAS  PubMed  Google Scholar 

  21. Eisenberg JM, Power EJ. Transforming insurance coverage into quality health care: voltage drops from potential to delivered quality. JAMA. 2000;284(16):2100–7.

    Article  CAS  PubMed  Google Scholar 

  22. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14(4):778–84.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Biadgilign S, Deribew A, Amberbir A, Deribe K. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: a qualitative study. SAHARA J. 2009;6(4):148–54.

    Article  PubMed  Google Scholar 

  24. Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.

    Article  CAS  PubMed  Google Scholar 

  25. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67.

    Article  CAS  PubMed  Google Scholar 

  27. Hutchinson PL, Mahlalela X. Utilization of voluntary counseling and testing services in the Eastern Cape, South Africa. AIDS Care. 2006;18(5):446–55.

    Article  CAS  PubMed  Google Scholar 

  28. Kaawa-Mafigiri D, Mcgrath J, Namutiibwa F, et al. Delays in seeking HIV/AIDS testing and treatment among patients on ARVs in urban (Kampala) and rural southwestern Uganda. XIX International AIDS Conference. Washington, DC, 2012.

  29. Morin SF, Khumalo-Sakutukwa G, Charlebois ED, et al. Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe. J Acquir Immune Defic Syndr. 2006;41(2):218–24.

    Article  PubMed  Google Scholar 

  30. Minstry of Health Uganda, ORC Macro. Uganda HIV/AIDS sero-behavioural survey 2004–2005. Calverton: Ministry of Health and ORC Macro; 2006.

  31. Amuron B, Namara G, Birungi J, et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009;9:290.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Parkes-Ratanshi R, Bufumbo L, Nyanzi-Wakholi B, et al. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Trop Med Int Health. 2010;15(11):1347–56.

    Article  PubMed  Google Scholar 

  33. Braitstein P, Songok J, Vreeman RC, et al. “Wamepotea” (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. J Acquir Immune Defic Syndr. 2011;57(3):e40–6.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Krebs DW, Chi BH, Mulenga Y, et al. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care. 2008;20(3):311–7.

    Article  CAS  PubMed  Google Scholar 

  35. McGuire M, Munyenyembe T, Szumilin E, et al. Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health. 2010;15(Suppl 1):55–62.

    Article  PubMed  Google Scholar 

  36. Ochieng-Ooko V, Ochieng D, Sidle JE, et al. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ. 2010;88(9):681–8.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Adeyemo A, Tamen F, Ayebe T, Oyigebe G. Socio-gender factors as explanation for poor drug adherence among antiretroviral users. 4th International Conference on HIV Treatment Adherence. Miami; 2009.

  38. Asiimwe B, Tarinyeba E, Kyomuhendo J. Adherence results for 84 patients on anti-retroviral therapy for 1 year at Bushenyi Medical Centre, Katungu in rural south western Uganda. 2nd International Conference on HIV Treatment Adherence. Miami; 2007.

  39. Bajunirwe F, Tisch DJ, King CH, Arts EJ, Debanne SM, Sethi AK. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda. AIDS Care. 2009;21(3):271–9.

    Article  PubMed  Google Scholar 

  40. Eholie SP, Tanon KA, Folquet-Amorissani M, et al. Impact of access to antiretroviral therapy in Cote d’Ivoire. Med Trop (Mars). 2009;69(5):520–4.

    CAS  PubMed  Google Scholar 

  41. Kip E, Ehlers VJ, van der Wal DM. Patients’ adherence to anti-retroviral therapy in Botswana. J Nurs Scholarsh. 2009;41(2):149–57.

    Article  PubMed  Google Scholar 

  42. Kirsten I, Sewangi J, Kunz A, et al. Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS ONE. 2011;6(6):e21020.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Munseri PJ, Talbot EA, Mtei L, von Reyn CF. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Int J Tuberc Lung Dis. 2008;12(9):1037–41.

    CAS  PubMed  Google Scholar 

  44. Olowookere SA, Fatiregun AA, Akinyemi JO, Bamgboye AE, Osagbemi GK. Prevalence and determinants of nonadherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria. J Infect Dev Ctries. 2008;2(5):369–72.

    PubMed  Google Scholar 

  45. Potchoo Y, Tchamdja K, Balogou A, Pitche VP, Guissou IP, Kassang EK. Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association “Espoir Vie Togo” in Togo, West Africa. BMC Clin Pharmacol. 2010;10:11.

    Article  PubMed Central  PubMed  Google Scholar 

  46. van Dijk JH, Sutcliffe CG, Munsanje B, Hamangaba F, Thuma PE, Moss WJ. Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis. BMC Infect Dis. 2009;9:169.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34(3):281–8.

    Article  PubMed  Google Scholar 

  48. Yahaya H, Gwarzo U, Liman MS. Forecasting long-term adherence to HAART in GHAIN-supported facility using client’s socioeconomic status. 1st International Conference on HIV Treatment Adherence. Miami; 2006.

  49. Assefa Y, Van Damme W, Mariam DH, Kloos H. Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS. 2010;24(8):521–5.

    Article  PubMed  Google Scholar 

  50. Bowie C, Gondwe N. Changing clinical needs of people living with AIDS and receiving home based care in Malawi: the Bangwe Home Based Care Project 2003–2008—a descriptive study. BMC Public Health. 2010;10:370–1.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Chan AK, van Lettow M, Tenthani L, et al. Outcome assessment of a dedicated HIV positive health care worker clinic at a central hospital in Malawi: a retrospective observational study. PLoS One. 2011;6(5):e19789.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Lubega M, Nsabagasani X, Tumwesigye NM, et al. Policy and practice, lost in transition: reasons for high drop-out from pre-antiretroviral care in a resource-poor setting of eastern Uganda. Health Policy. 2010;95(2–3):153–8.

    Article  PubMed  Google Scholar 

  53. Bwirire LD, Fitzgerald M, Zachariah R, et al. Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi. Trans R Soc Trop Med Hyg. 2008;102(12):1195–200.

    Article  CAS  PubMed  Google Scholar 

  54. Abrahams N, Jewkes R. Barriers to post exposure prophylaxis (PEP) completion after rape: a South African qualitative study. Cult Health Sex. 2010;12(5):471–84.

    Article  PubMed  Google Scholar 

  55. Byakika-Tusiime J, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV+Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13(Suppl 1):82–91.

    Article  PubMed  Google Scholar 

  56. Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 2008;67(2):301–10.

    Article  PubMed  Google Scholar 

  57. Nassali M, Nakanjako D, Kyabayinze D, Beyeza J, Okoth A, Mutyaba T. Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program. AIDS Care. 2009;21(9):1124–31.

    Article  PubMed  Google Scholar 

  58. Peterson K, Laly R. Patterns in the use of adherence supports. 1st International Conference on HIV Treatment Adherence. Miami; 2006.

  59. Pyne-Mercier LD, John-Stewart GC, Richardson BA, et al. The consequences of post-election violence on antiretroviral HIV therapy in Kenya. Aids Care. 2011;23(5):562–8.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? Int J Tuberc Lung Dis. 2005;9(3):263–9.

    CAS  PubMed  Google Scholar 

  61. Thobias A, Van Wyk B. Issues in adherence to antiretroviral treatment in an urban setting in Namibia. 4th International Conference on HIV Treatment Adherence. Miami; 2009.

  62. Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1):e11.

    Article  PubMed  Google Scholar 

  63. Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One. 2010;5(4):e10340.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  64. Wringe A, Isingo R, Urassa M, et al. Uptake of HIV voluntary counselling and testing services in rural Tanzania: implications for effective HIV prevention and equitable access to treatment. Trop Med Int Health. 2008;13(3):319–27.

    Article  PubMed  Google Scholar 

  65. Cook RE, Ciampa PJ, Sidat M, et al. Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambezia, Mozambique. J Acquir Immune Defic Syndr. 2011;56(4):e104–9.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Ingle SM, May M, Uebel K, et al. Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS. 2010;24(17):2717–25.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Lessells RJ, Mutevedzi PC, Cooke GS, Newell ML. Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2011;56(3):e79–86.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Sutcliffe CG, van Dijk JH, Bolton-Moore C, Cotham M, Tambatamba B, Moss WJ. Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural Zambia. Pediatr Infect Dis J. 2010;29(9):849–54.

    Article  PubMed  Google Scholar 

  69. Elbireer S, Guwatudde D, Mudiope P, Nabbuye-Sekandi J, Manabe YC. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda. Trop Med Int Health. 2011;16(8):981–7.

    Article  PubMed  Google Scholar 

  70. Geng EH, Glidden DV, Bwana MB, et al. Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS One. 2011;6(7):e21797.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  71. Karcher H, Omondi A, Odera J, Kunz A, Harms G. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health. 2007;12(5):687–94.

    Article  PubMed  Google Scholar 

  72. Kempf MC, Allen S, Zulu I, et al. Enrollment and retention of HIV discordant couples in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;47(1):116–25.

    Article  PubMed  Google Scholar 

  73. Massaquoi M, Zachariah R, Manzi M, et al. Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Trans R Soc Trop Med Hyg. 2009;103(6):594–600.

    Article  CAS  PubMed  Google Scholar 

  74. Mossdorf E, Stoeckle M, Mwaigomole EG, et al. Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. BMC Infect Dis. 2011;11:98.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Mulissa Z, Jerene D, Lindtjorn B. Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS ONE. 2010;5(10):e13268.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  76. Adeyemi A, Olubunmi F, Oluseyi A. Predictors of adherence for patients on highly active antiretroviral therapy in HIV treatment program. 12th Annual International Meeting of the Institute of Human Virology. Tropea; 2010.

  77. Bagenda A, Barlow-Mosha L, Bagenda D, Sakwa R, Fowler MG, Musoke PM. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda. Ann Trop Paediatr. 2011;31(3):235–45.

    Article  CAS  PubMed  Google Scholar 

  78. Barth RE, Tempelman HA, Smelt E, Wensing AM, Hoepelman AI, Geelen SP. Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment. Pediatr Infect Dis J. 2011;30(1):52–6.

    Article  PubMed  Google Scholar 

  79. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV plus Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16(1):38–41.

    Article  CAS  PubMed  Google Scholar 

  80. Carlucci JG, Kamanga A, Sheneberger R, et al. Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr. 2008;47(5):615–22.

    Article  PubMed Central  PubMed  Google Scholar 

  81. Charurat M, Oyegunle M, Benjamin R, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS ONE. 2010;5(5):e10584.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  82. Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS ONE. 2012;7(5):e36737.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  83. Hirschhorn L, Singal R, Navario P, Mokhele I, Patel A, Maartens G. Adherence to ART in two innovative treatment models in South Africa. 4th International Conference on HIV Treatment Adherence. Miami; 2009.

  84. Iroha E, Esezobor CI, Ezeaka C, Temiye EO, Akinsulie A. Adherence to antiretroviral therapy among HIV-infected children attending a donor-funded clinic at a tertiary hospital in Nigeria. AJAR-Afr J Aids Res. 2010;9(1):25–30.

    Article  Google Scholar 

  85. Kurlander C, Eng ML, Charurat M, Farley JJ, Blattner WA. Evaluation of pharmacy refill rates and self-reported adherence for antiretroviral therapy at a PEPFAR clinic in northern Nigeria. 2nd International Conference on HIV Treatment Adherence. Miami; 2007.

  86. Maqutu D, Zewotir T, North D, Naidoo K, Grobler A. Factors affecting first-month adherence to antiretroviral therapy among HIV-positive adults in South Africa. AJAR-Afr J Aids Res. 2010;9(2):117–24.

    Article  Google Scholar 

  87. Mbaezue N, Farley J, Charurat M, Blattner WA. A case control study of nonadherence among Nigerian patients initiating antiretroviral (ARV) therapy. 2nd International Conference on HIV Treatment Adherence. Miami; 2007.

  88. Ramadhani HO, Thielman NM, Landman KZ, et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis. 2007;45(11):1492–8.

    Article  PubMed  Google Scholar 

  89. Sethi A, Bajunirwe F, Mafigiri D, et al. Distance as a barrier to adherence to antiretroviral therapy among HIV-infected patients in rural southwestern Uganda. 4th International Conference on HIV Treatment Adherence. Miami; 2009.

  90. Taiwo BO, Idoko JA, Welty LJ, et al. Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting. J Acquir Immune Defic Syndr. 2010;54(1):85–92.

    Article  PubMed  Google Scholar 

  91. van Dijk JH, Sutcliffe CG, Munsanje B, et al. HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS One. 2011;6(4):e19006.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  92. Bateman J, Garrod GD, Brainard JS, Lovett AS. Measurement issues in the travel cost method: a geographical information systems approach. J Agric Econ. 1996;47(2):191–205.

    Article  Google Scholar 

  93. Siedner MJ, Lankowski A, Tsai AC, et al. GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS. 2013;27(9):1503–8.

    Article  PubMed Central  PubMed  Google Scholar 

  94. Tsai AC, Bangsberg DR, Weiser SD. Harnessing poverty alleviation to reduce the stigma of HIV in Sub-Saharan Africa. PLoS Med. 2013;10(11):e1001557.

    Article  PubMed Central  PubMed  Google Scholar 

  95. Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR. HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav. 2011;15(6):1111–20.

    Article  PubMed Central  PubMed  Google Scholar 

  96. Tsai AC, Bangsberg DR, Kegeles SM, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013;46(3):285–94.

    Article  PubMed  Google Scholar 

  97. Naar-King S, Bradford J, Coleman S, Green-Jones M, Cabral H, Tobias C. Retention in care of persons newly diagnosed with HIV: outcomes of the Outreach Initiative. AIDS Patient Care STDS. 2007;21(Suppl 1):S40–8.

    PubMed  Google Scholar 

  98. Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 Suppl 2):18640.

    PubMed Central  PubMed  Google Scholar 

  99. Mekonnen Y, Sanders R, Tibebu S, Emmart P. Equity and access to ART in Ethiopia. Washington, DC: Futures Group, Health Policy Initiative; 2010.

    Google Scholar 

  100. Mahler HR, Kileo B, Curran K, et al. Voluntary medical male circumcision: matching demand and supply with quality and efficiency in a high-volume campaign in Iringa Region, Tanzania. PLoS Med. 2011;8(11):e1001131.

    Article  PubMed Central  PubMed  Google Scholar 

  101. Gilbert L, Walker L. ‘My biggest fear was that people would reject me once they knew my status…’: stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa. Health Soc Care Community. 2010;18(2):139–46.

    Article  PubMed  Google Scholar 

  102. Wilson DP, Blower S. How far will we need to go to reach HIV-infected people in rural South Africa? BMC Med. 2007;5:16.

    Article  PubMed Central  PubMed  Google Scholar 

  103. Boyer S, Eboko F, Camara M, et al. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS. 2010;24(Suppl 1):S5–15.

    Article  PubMed  Google Scholar 

  104. Bemelmans M, van den Akker T, Ford N, et al. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health. 2010;15(12):1413–20.

    Article  PubMed  Google Scholar 

  105. Pfeiffer J, Montoya P, Baptista AJ, et al. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique: a case study. J Int AIDS Soc. 2010;13:3.

    Article  PubMed Central  PubMed  Google Scholar 

  106. Tsai AC, Chopra M, Pronyk PM, Martinson NA. Socioeconomic disparities in access to HIV/AIDS treatment programs in resource-limited settings. AIDS Care. 2009;21(1):59–63.

    Article  PubMed  Google Scholar 

  107. Siedner MJ, Lankowski A, Haberer JE, et al. Rethinking the “pre” in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS ONE. 2012;7(6):e39894.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  108. Wilson DP, Blower SM. Designing equitable antiretroviral allocation strategies in resource-constrained countries. PLoS Med. 2005;2(2):e50.

    Article  PubMed Central  PubMed  Google Scholar 

  109. Jani IV, Sitoe NE, Alfai ER, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011;378(9802):1572–9.

    Article  PubMed  Google Scholar 

  110. Wanyenze RK, Hahn JA, Liechty CA, et al. Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav. 2011;15(4):751–60.

    Article  PubMed Central  PubMed  Google Scholar 

  111. Siedner MJ, Haberer JE, Bwana MB, Ware NC, Bangsberg DR. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak. 2012;12:56.

    Article  PubMed Central  PubMed  Google Scholar 

  112. Emenyonu N, Thirumurthy H, Muyindike W, et al. Cash transfers to cover clinic transportation costs improve adherence and retention in care in a HIV treatment program in Rural Uganda. 17th Conference on Retroviruses and Opportunistic Infections. San Francisco; 2010.

  113. Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H. Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S123–6.

    Article  PubMed  Google Scholar 

  114. Haberer JE, Kiwanuka J, Nansera D, et al. Real-time adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS. 2013;27(13):2166–8.

    Article  PubMed  Google Scholar 

  115. Bachman Desilva M, Gifford AL, Keyi X, et al. Feasibility and acceptability of a real-time adherence device among HIV-positive IDU patients in China. AIDS Res Treat. 2013;2013:957862.

    PubMed Central  PubMed  Google Scholar 

  116. Haberer JE, Robbins GK, Ybarra M, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16(2):375–82.

    Article  PubMed Central  PubMed  Google Scholar 

  117. Haberer JE, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14(6):1340–6.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Doris Duke Charitable Foundation International Clinical Research Fellowship at Harvard Medical School; the American Medical Association Foundation Seed Grant Research Program; and the U.S. National Institutes of Health R24TW007988, K23MH099916, K24MH087227, and K23MH096620. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Departments of Internal Medicine and Pediatrics, University of Pennsylvania, Philadelphia, PA, USA

    Alexander J. Lankowski

  2. Center for Global Health, Massachusetts General Hospital, 100 Cambridge Street, 15th Floor, Boston, MA, 02114, USA

    Alexander J. Lankowski, Mark J. Siedner, David R. Bangsberg & Alexander C. Tsai

  3. Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard Medical School, Cambridge, MA, USA

    David R. Bangsberg

  4. Mbarara University of Science and Technology, Mbarara, Uganda

    David R. Bangsberg & Alexander C. Tsai

  5. Chester M. Pierce Division of Global Psychiatry, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA

    Alexander C. Tsai

Authors
  1. Alexander J. Lankowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark J. Siedner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David R. Bangsberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexander C. Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander J. Lankowski.

Additional information

Alexander J. Lankowski and Mark J. Siedner have contributed equally to this work.

Appendix

Appendix

Search Terms Used in PubMed and Web of Science

  1. 1.

    PubMed search performed 8/14/11.

    (“mortality”[MH] or “survival”[TIAB] or “patient dropouts”[MH] or “lost to follow up”[MH] or retention[TIAB] or default[TIAB] or interruption[TIAB] or “linkage”[TIAB] or “medication adherence”[MH] OR “patient compliance”[MH] or “adherence”[TIAB] or “non-adherence”[TIAB] or “compliance”[TIAB] OR “non-compliance”[TIAB]) AND “africa south of the sahara”[MH] AND (“acquired immunodeficiency syndrome”[MH] OR “HIV”[TIAB] OR “AIDS”[TIAB]) AND (distance[TIAB] or “health services accessibility”[MH] or travel[TIAB] or barriers[TIAB] or structural[TIAB] or rural[TIAB] or “rural health services”[MH] or “rural population”[MH] or “hospitals, rural”[MH]).

  2. 2.

    Web of Science search performed 8/14/11.

    TS = (“SSA” OR Africa) AND TS = (“loss to follow up” OR mortality OR survival OR default OR interruption OR linkage OR “non-compliance” OR compliance OR adherence OR “non-adherence”) AND TS = (“human immunodeficiency virus” OR HIV OR “acquired immunodeficiency syndrome” OR “acquired immune deficiency syndrome” OR AIDS) AND TS = (distance or “health services accessibility” or travel or barriers or structural or rural or “rural health services” or “rural population” or “hospitals, rural”).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lankowski, A.J., Siedner, M.J., Bangsberg, D.R. et al. Impact of Geographic and Transportation-Related Barriers on HIV Outcomes in Sub-Saharan Africa: A Systematic Review. AIDS Behav 18, 1199–1223 (2014). https://doi.org/10.1007/s10461-014-0729-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-014-0729-8

Keywords

Search

Navigation